|
RAP1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.683500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.475010E-01 |
| Normal-vs-Stage2 |
8.438400E-03 |
| Normal-vs-Stage3 |
4.922400E-02 |
| Normal-vs-Stage4 |
9.824800E-04 |
| Stage1-vs-Stage2 |
8.963600E-02 |
| Stage1-vs-Stage3 |
3.461600E-01 |
| Stage1-vs-Stage4 |
1.652100E-02 |
| Stage2-vs-Stage3 |
3.782600E-01 |
| Stage2-vs-Stage4 |
5.996600E-01 |
| Stage3-vs-Stage4 |
1.361360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.558000E-02 |
| Normal-vs-AfricanAmerican |
3.115900E-02 |
| Normal-vs-Asian |
1.118790E-01 |
| Caucasian-vs-AfricanAmerican |
3.392800E-01 |
| Caucasian-vs-Asian |
8.843000E-01 |
| AfricanAmerican-vs-Asian |
3.958800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.118000E-02 |
| Normal-vs-Female |
3.160200E-02 |
| Male-vs-Female |
7.712600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.847600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.496360E-02 |
| Normal-vs-Age(61-80Yrs) |
2.875900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.719000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.069700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.015530E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.152600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.797200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.063440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.041600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.442400E-01 |
| Classical-VS-Follicular |
1.403390E-03 |
| Classical-VS-Other |
1.330430E-01 |
| Classical-VS-Normal |
2.315800E-01 |
| Tall-VS-Follicular |
8.871600E-02 |
| Tall-VS-Other |
2.696000E-01 |
| Tall-VS-Normal |
3.422600E-01 |
| Follicular-VS-Other |
8.374000E-01 |
| Follicular-VS-Normal |
7.180600E-04 |
| Other-VS-Normal |
6.416000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.435500E-03 |
| Normal-vs-N1 |
1.604080E-03 |
| N0-vs-N1 |
4.574200E-01 |
|
|
